CS logo
small CS logo
Matrix Clinical Research

Los Angeles, California, United States
Research institute in Los Angeles, California
1919 W 7th St, Los Angeles, CA 90057

About Matrix Clinical Research


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Celgene
3
Pfizer
3
BioNTech SE
2
Bavarian Nordic
1
Evofem Inc.
1
Evolve BioSystems, Inc.
1
Total Rows: 6

Clinical Trials at Matrix Clinical Research


During the past decade, Matrix Clinical Research conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years44112222220000000011Started TrialsCompleted Trails201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
2018-03-07
2024-06-28
Recruiting
600
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
2018-06-27
2025-06-24
Recruiting
485
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
2018-08-24
2029-12-27
Recruiting
1,200
User Testing of the Evivo Screening Test
2018-08-01
2019-04-24
Terminated
231
A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN
2019-08-07
2021-09-30
Completed
1,153
A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.
2020-06-17
2023-11-24
Active, not recruiting
14,750
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection
2020-10-15
2022-07-28
Active, not recruiting
1,730
To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older
2021-02-16
2022-07-15
Completed
349

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Matrix Clinical Research" #1 sponsor was "Celgene" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "BioNTech SE" with 2 trials sponsored, "Bavarian Nordic" with 1 trials sponsored and "Evofem Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Matrix Clinical Research" #1 collaborator was "Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsCelgene: 3Celgene: 3Pfizer: 3Pfizer: 3BioNTech SE: 2BioNTech SE: 2Bavarian Nordic: 1Bavarian Nordic: 1Evofem Inc.: 1Evofem Inc.: 1Evolve BioSystems, Inc.: 1Evolve BioSystems, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsPfizer: 2Pfizer: 2

Clinical Trials Conditions at Matrix Clinical Research


According to Clinical.Site data, the most researched conditions in "Matrix Clinical Research" are "Crohn Disease" (3 trials), "COVID-19" (2 trials), "Respiratory Tract Infection" (2 trials), "Chlamydia" (1 trials) and "Gonorrhea" (1 trials). Many other conditions were trialed in "Matrix Clinical Research" in a lesser frequency.

Clinical Trials Intervention Types at Matrix Clinical Research


Most popular intervention types in "Matrix Clinical Research" are "Biological" (5 trials), "Drug" (5 trials), "Other" (4 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Ozanimod" (3 trials), "BNT162b2" (1 trials), "BNT162b2 20mcg" (1 trials) and "BNT162b2 30mcg" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Matrix Clinical Research


The vast majority of trials in "Matrix Clinical Research" are 7 trials for "All" genders and 4 trials for "Female" genders.

Clinical Trials Status at Matrix Clinical Research


Currently, there are NaN active trials in "Matrix Clinical Research". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Matrix Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Matrix Clinical Research, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 8Phase 3: 8Phase 2: 3Phase 2: 3Not Applicable: 1Not Applicable: 1Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 4Active, not recruiting: 4Recruiting: 4Recruiting: 4Completed: 2Completed: 2Terminated: 1Terminated: 1